NRXPW vs RIVN · rev $242.0K vs rev $1.66B
NRx Pharmaceuticals Inc (NRXPW) versus Rivian Automotive Inc (RIVN) — a side-by-side from cached financials, not a winner call.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by Robert Joseph Scaringe Ph.D..
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
Latest reported RIVN revenue for 2026-06-30 was $1.66B. Net income was -$833.0M. Revenue was up 20.1% from 2026-03-31 to 2026-06-30. RIVN currently screens at market cap $21.81B.
NRXPW currently screens at market cap $714.6M. RIVN currently screens at market cap $21.81B.
Not investment advice. Open the NRXPW and RIVN stock pages for the full models.
Not investment advice.